🏛️ Verified NIH Record • Updated 2025-12-04
Use of GeriKit to Better Phenotype Older Adults With Ischemic Heart Disease (NCT05788666)
🟢 Recruiting Observational / Diagnostic 🩺 Clinical Procedure Protocol Sponsor: NYU Langone Health
🩺 Plain-English Summary (8th-Grade Level)
This study seeks to expand the use of the NYU GeriKit mobile application ("app") in a diverse range of settings to better phenotype older patients, which will enhance both research and patient care.
Who can join: Review the eligibility criteria below.
Location: NYU Langone Health — New York, New York
Age range: 75 Years to 100 Years
🧪 Interventions in This Study
- GeriKit Mobile Application (PROCEDURE)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- NYU Langone Health — New York, New York
📞 Contact the Study Coordinator
Phone: (646) 501-2714
Email: Cdhlab@nyulangone.org
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Ischemic Heart Disease
Explore by condition: All Ischemic Heart Disease clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.